Coca-Cola's brand value declined to $33.2 billion but retained its title as the world's most valuable and strongest soft drink brand, with second place Pepsi posting a much lower brand value of $18.4 billion.
The third to tenth places in Brand Finance's rankings were occupied by Red Bull, Nescafe, Monster Energy, Sprite, Gatorade, Dr. Pepper, Mountain Dew, and Lipton.
Meanwhile, Dr. Pepper exhibited the strongest soft drink brand growth of 40 percent with Red Bull trailing it with 15 percent.
Softdrink brands were the most severely impacted by the pandemic, with the world's top 25 declining in value by 6 percent from $114.8 billion in 2020 to 107.5 billion in 2021.
In terms of overall portfolios, Nestle came out on top with $65.6 billion. Among Nestle's many products were Nespresso and Nescafe.
PepsiCo took second place with a portfolio value of $59.2 billion, while The Coca-Cola Company took third place with $48.6 billion.
Brand Finance noted that while Coca-Cola remains to be the world's most consumed soda with 1.9 billion daily servings across 200 countries, the brand's parent company needed to restructure and cut 2,000 jobs due to COVID-19's impact.
Occupying the fourth to tenth places in top portfolio performances were Unilever, Mars, Danone, Mondelez, KraftHeinz, Groupe Lactalis, and General Mills.


Google to Buy Spirit Airlines Business Data for $10 Million to Train AI
Anthropic Eyes $10B-Plus Credit Line Ahead of Potential IPO
Nvidia’s $500 Billion AI Infrastructure Push Wins Morgan Stanley Support
US Dollar Holds Steady as Fed Rate Bets and Iran Tensions Drive Markets
China Set to Hold Benchmark Lending Rates Steady for 15th Month
Canada Faces 50% U.S. Tariffs as Trade Tensions Threaten USMCA Talks
US Stock Futures Mixed as Fed Rate Hike Bets Fade, AI Deals in Focus
Shein Targets $26B-$27B Valuation for Hong Kong IPO
Alphabet Eyes First Australian Dollar Bond as AI Spending Drives Funding Push
Asian Stocks Slide as Chip Selloff and High Bond Yields Hit Markets
OpenAI Revenue Rises 18% in Q2 as Losses Widen and Anthropic Surges Ahead
Lockheed Martin Secures $153.5 Million in U.S. Defense Contracts
Switzerland Industrial Production Jumps 5.5% in Q2 2026
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback
Synlait Milk Denies Fonterra, a2 Milk Takeover Talks 



